-
Cell Res: Zeng Musan/Bai Fan/Zhong Xi collaborated to discover the "skin-immunity" dual characteristic tumor cells of nasopharyngeal cancer and their important biological functions.
Time of Update: 2020-09-24
Nasopharyngeal carcinoma (NPC) is a malignant tumor associated with genetic, environmental and other factors, with higher incidence rates in southern China, Southeast Asia and other regions. because
-
Lancet Glob Health: Low-cost oral rhythm chemotherapy to treat relapsed metastatic head and neck cancer.
Time of Update: 2020-09-24
the medium follow-up of (overall survival of intentional treatment population) was 15.73 months, the medium total survival of oral rhythm chemotherapy group was 7.5 months (IQR4.6-12.6), while intravenous cisplatin group was not 6.1 months (3.2-9.6 months) (unedjusted risk of death ratio of 0.773 (95% CI 0.615-0.97, p=0.026) ).
-
Junshi "Terripley single resistance": the first FDA breakthrough therapy identified as the domestic PD-1.
Time of Update: 2020-09-24
announcement, the Terripri single-drug treatment for nasopharyngeal cancer has been recognized by the FDA as a breakthrough therapy that significantly supports and accelerates the drug's commercial development program in the United States.
-
Cell Death Dis:LINC01559 activates the PI3K/AKT signaling path path, which promotes the development of stomach cancer.
Time of Update: 2020-09-24
, the study showed that LINC01559 was able to activate the PI3K/AKT signaling path by raising PPK1 and lowering PTEN expression levels, ultimately promoting the development of GC, suggesting that LINC01559 may be a potential biomarker in the treatment of stomach cancer.
-
NERLYNX (neratinib) treatment of HER2-positive metastasis breast cancer: will be approved in Canada.
Time of Update: 2020-09-24
pharmaceutical company Knight announced today that it has filed a supplementary document (SNDS) in Canada for the declaration of a new drug for THELYNX (neratinib) to treat HER2-positive metastasis breast cancer.
Tykerb® (Lapatini) combined with Capatinib to treat HER2-positive metastasis breast cancer patients.
-
Blood: BCR-ABL1 early dynamics predict the long-term prognostication of CML treatment-free remission.
Time of Update: 2020-09-24
early molecular reaction dynamics were evaluated as a predictor by calculating the time unique to BCR-ABL1 after patients were treated with tyrosine kinase inhibitors (TKI).
, the BCR-ABL1 value detected during the 3 months of TKI treatment was not an independent predictor of persistent TFR.
-
Cell Death Dis: The small molecular compound AH057 and SGI-1027 inhibit the development of cervical cancer cells.
Time of Update: 2020-09-24
the study identified a variety of candidates for new JAK inhibitors by simulating the screening of the SPECS database, and assessed the anti-tumor effects of these candidate drugs, especially on CC cell line.
-
Beijing Cancer Prevention and Control Society Esophageal Cancer Commission was established to lead China's esophageal cancer diagnosis and treatment into a new stage.
Time of Update: 2020-09-24
Today (September 6), in order to promote the national esophageal cancer in many fields of authoritative experts to explore and exchange, leading China's comprehensive diagnosis and treatment of esopha
-
72-year-old belly buried "bomb" and tongue cancer, doctors boldly broke through the "surgical exclusion zone" successfully cut the tumor.
Time of Update: 2020-09-24
Professor Pan Chaobin, director of oral maxillofacial surgery at the hospital, after receiving Guo Bo, jointly consulted with several departments to develop a well-developed surgical plan, which resulted in the successful removing of the entire tongue and tumor, and repaired the defects of the whole tongue.
-
Cell Death Differ: EZH2 R342 methylation modification promotes breast cancer metastasis.
Time of Update: 2020-09-24
researchers also found that meR342-EZH2 can lead to lower levels of target gene expression in EZH2 and improve EMT processes, cell invasion, and tumor metastasis in breast cancer cells.
-
Take stock: A selection of BMJ studies on September 12, 2020.
Time of Update: 2020-09-24
: Doi: https://doi.org/10.1136/bmj.m2651 Researchers recently quantified the predicted value of accidental weight loss (WL) for tumor diagnosis based on the patient's age, sex, smoking status and clinical characteristics (symptoms, signs, and abnormal blood test results).
-
Hengrun Dasheng completed 200 million yuan B-plus round of financing, plus code cell therapy industrialization layout.
Time of Update: 2020-09-24
Recently, Zhangjiang Science City cell therapy company Shanghai Hengrun Dasheng Biotech Co., Ltd. (hereinafter referred to as "Hangrun Dasheng") announced the completion of 200 million yuan B-plus rou
-
The second CAR-T therapy declared for sale in China was eligible for the "Priority Review plus Breakthrough Drugs" double review.
Time of Update: 2020-09-24
Recently, according to the latest publicity of the Drug Review Center of the State Drug Administration, Zhangjiang Science City Enterprise Drug Ming Juno's Ricky Lunsai injection (tentative name, rese
-
Keystone Pharmaceuticals RET inhibitor Platinib's China listing application was accepted and included in the priority review.
Time of Update: 2020-09-24
Recently, China's State Drug Administration (NMPA) formally accepted the application for the listing of Pralsetinib capsules and included them in the priority review for the treatment of patients with RET fusion-positive non-small cell lung cancer (NSCLC) with platinum-containing chemotherapy.
-
Nat Commun: Genomics of worsening pancreatic cysts.
Time of Update: 2020-09-24
the results show that non-immersive IPMN and MCN are the origin of immersive pancreatic cancer, identify potential leaching drivers, reveal the complex cloning dynamic process before tumor malignant transformation, and provide data support for early detection and intervention of cancer.
-
Black technology explosion: an ice knife "frozen to death" tumor, the next day can be discharged from the hospital...
Time of Update: 2020-09-24
If there is magic freezing will be a lot of people want to have in many fantasy film and television works we often see the main character's hand, the person in front of the instant freezing want who "
-
Can cancer patients have children? What's the impact on your child?
Time of Update: 2020-09-24
Finally, during pregnancy, it is necessary for women to pay a lot of energy and physical strength, especially nutrition supply work must be done well, but some women during pregnancy, not only will appear nausea and vomiting, cancer will vomit, which will lead to patients eating more difficult, a long time, whether for pregnant women or fetuses, are very unfavorable, easy to risk.
-
Take stock: A selection of BMJ studies on September 5, 2020.
Time of Update: 2020-09-24
Vaccination against HPV does not increase the risk of autoneural neurodefunction syndrome in women Doi: https://doi.org/10.1136/bmj.m2930 Researchers recently assessed the risk of autoneuric neurodefunction syndrome associated with the 4-price HPV vaccine, including chronic fatigue syndrome, complex area pain syndrome, and erect TPD syndrome.
-
Big data reveals the characteristics of pancreatic tumors in China: pancreatic cancer 'son-in-law'
Time of Update: 2020-09-24
The incidence of pancreatic cancer, known as the "King of Cancer" in China, increases year by year, the recurrence rate is high after surgery and the mortality rate is high, but the early diagnosis ra
-
Nat Rev Cancer: The most cancer-driven gene panorama to date, with a total of 568 cancer-causing genes in 66 cancers.
Time of Update: 2020-09-24
identified the 568 cancer-driven genes, the researchers observed that most genes were highly specific and that their mutations triggered only a few tumor types.
, scientists have discovered hundreds of cancer-driven genes in less than two decades since sequencing the first tumor genome.
